Hélène Cavé

Overview

Best Publications

• Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

  J Gabert;E Beillard;V H J van der Velden;W Bi

  2222
  Citations

• Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

  Cavé H;van der Werff ten Bosch J;Suciu S;Guidal C

  977
  Citations

• Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

  V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  853
  Citations

• Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus

  Andrey P. Babenko;Michel Polak;Hélène Cavé;Kanetee Busiah

  792
  Citations

• The MLL recombinome of acute leukemias in 2017

  C Meyer;T Burmeister;D Gröger;G Tsaur

  698
  Citations

• Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

  Tetsuya Niihori;Yoko Aoki;Yoko Narumi;Giovanni Neri

  671
  Citations

• The MLL recombinome of acute leukemias in 2013

  C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  567
  Citations

• New insights to the MLL recombinome of acute leukemias

  C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  512
  Citations

• Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

  M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer

  447
  Citations

• Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

  Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti

  442
  Citations

• Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

  Kheira Beldjord;Sylvie Chevret;Vahid Asnafi;Françoise Huguet

  348
  Citations

• Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.

  Reuben Benjamin;Reuben Benjamin;Charlotte Graham;Charlotte Graham;Deborah Yallop;Agnieszka Jozwik;Agnieszka Jozwik

  338
  Citations

• The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

  S Raynaud;H Cave;M Baens;C Bastard

  315
  Citations

• Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome

  Caroline Nava;Nadine Hanna;Caroline Michot;Sabrina Pereira

  295
  Citations

• Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

  Trudy D. Buitenkamp;Shai Izraeli;Martin Zimmermann;Erik Forestier

  277
  Citations

• Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

  E Vilmer;Stefan Suciu;Alina Ferster;Yves Bertrand

  273
  Citations

• IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

  Martin Stanulla;Elif Dagdan;Marketa Zaliova;Anja Möricke

  264
  Citations

• Kir6.2 Mutations Are a Common Cause of Permanent Neonatal Diabetes in a Large Cohort of French Patients

  Martine Vaxillaire;Céline Populaire;Kanetee Busiah;Hélène Cavé

  256
  Citations

• Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases

  B. Kerr;M. A. Delrue;S. Sigaudy;R. Perveen

  250
  Citations

• Genomics and drug profiling of fatal TCF3-HLF− positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

  Ute Fischer;Michael Forster;Anna Maria Rinaldi;Thomas S. Risch

  241
  Citations